Epidemiological studies indicate that children born small for gestational age (SGA) have an increased risk of metabolic and cardiovascular disorders as adults. This suggests that foetal undernutrition leads to permanent metabolic alterations, which predispose to metabolic abnormalities upon exposure to environmental factors such as low physical activity and/or high-energy intake in later life (thrifty phenotype hypothesis). However, this relationship is not restricted to foetal undernutrition or intrauterine growth retardation, but is also found for children born premature, or for high birth weight children. Furthermore, early post-natal nutrition, and more specifically catch-up growth, appear to modulate cardiovascular risk as well. Intrauterine growth retardation can be induced in animal models by energy/protein restriction, or ligation of uterine arteries. In such models, altered glucose homeostasis, including low beta-cell mass, low insulin secretion and insulin resistance is observed after a few weeks of age. In humans, several studies have confirmed that children born SGA have insulin resistance as adolescents and young adults. Alterations of glucose homeostasis and increased lipid oxidation can indeed be observed already in non-diabetic children born SGA at early pubertal stages. These children also have alterations of stature and changes in body composition (increased fat mass), which may contribute to the pathogenesis of insulin resistance. Permanent metabolic changes induced by foetal/early neonatal nutrition (metabolic inprinting) may involve modulation of gene expression through DNA methylation, or alterations of organ structure. It is also possible that events occurring during foetal/neonatal development lead to long-lasting alterations of the hypothalamo-pituitary-adrenal axis or the hypothalamo-pituitary-insulin-like growth factor-1 axis.
Introduction
There is robust epidemiological and experimental evidence that low birth weight is associated with an increased risk of developing type 2 diabetes, high blood pressure and cardiovascular diseases, dyslipidaemia and possibly obesity in later life. [1] [2] [3] [4] [5] Interestingly, these conditions often occur in clusters and their simultaneous occurrence in the same individuals corresponds to what has now been called the metabolic syndrome. 6 This evidence is based on large epidemiological studies and has led to the hypothesis that foetal undernutrition, a common cause for low birth weight (whether due to maternal undernutrition as during the Dutch famine 3, 7 or to placental failure leading to impaired delivery of oxygen and substrate to the foetus) may predispose to metabolic syndrome. As insulin resistance has been proposed as a possible (although disputed) aetiological factor in this syndrome, 6 considerable interest has arisen regarding the long-term consequences of foetal nutrition on insulin secretion and actions. The existence of a link between foetal nutrition and glucose homeostasis has subsequently been largely supported by animal experiments in which the delivery of nutrients to the foetus was decreased through manipulation of maternal diet or placental blood supply. Thus, feeding an energy-restricted or protein-restricted diet to female pregnant rats led to alterations of glucose metabolism in the offspring. 8, 9 Similarly, decreasing the delivery of nutrients to the foetus by a partial ligation of uterine arteries in pregnant female rats or by uterine artery embolization in pregnant sheep leads to similar alterations. 10 Altogether, this epidemiological and experimental evidence have led authors to propose the hypothesis that foetal nutrient restriction leads to the development of a thrifty phenotype which will persist throughout the life of the individual. This phenotype, aiming at sparing energy and the few nutrients available during gestation for brain and major organ development would, however, predispose to the development of obesity and associated co-morbidities if the individual becomes exposed to a nutrient overload in later life.
Experimental data regarding foetal/neonatal nutrition and metabolic disorders
Since the initial formulation of this hypothesis by Barker and Hales, the relationship between foetal nutrition and metabolic disorders has been the topic of a large number of studies, essentially supporting the original hypothesis. These experiments, performed in animals, clearly document that foetal nutrition actually impacts on glucose homeostasis. The role it plays in the current epidemics of obesity and type 2 diabetes remains, however, speculative at this time.
Low birth weight, secondary to maternal undernutrition, has indeed become rare in industrialized countries where diabetes and obesity are highly prevalent. 12 In such countries, low birth weight is more often linked to vascular placental failure or to exposure to toxins such as alcohol. In addition, it has been recently reported that not only smallness for gestational age (i.e., an index suggestive of foetal nutrient deprivation), but also the time of gestation is related to metabolic disorders. 13 Thus, the insulin sensitivity was observed to be lower in children born premature than in children born at term, irrespective of weight for gestational age. Furthermore, not only birth weight or foetal nutrition appears to play an important role, but also post-natal nutrition. It has indeed been shown on several occasions that, in children born small for gestational age (SGA), rapid catch-up growth during the first year postnatal specifically impairs insulin secretion and action. 14 Finally, increased metabolic risk is seen not only with low birth weight, but also with high birth weight. 15 Thus, although there is strong evidence that foetal nutrition impacts on metabolic homeostasis in later life, the effects of maternal/foetal and neonatal nutrition appear highly complex and far from unravelled.
Effects of intrauterine growth retardation in animal model
Intrauterine growth retardation (IUGR) can be induced in experimental animal models by energy restriction, 16 or by feeding an isoenergetic low-protein diet [17] [18] during pregnancy. Decreased foetal nutritional delivery can also be induced by ligation of uterine arteries of pregnant rats. 19 Impaired glucose tolerance (IGT) is observed after 1 week in rats born with IUGR. 10, 20 Investigations indicate that glucose-insulin secretion is decreased after IUGR. 21 In addition, the number of pancreatic beta cells and of pancreatic islet insulin content is decreased. [21] [22] These observations suggest that IUGR leads, directly or indirectly, to impaired beta cell development and/or proliferation and disturbed beta cell responsiveness to glucose. Insulin resistance can also be documented at the whole body level and in skeletal muscle and adipose tissue of IUGR rats by euglycaemic hyperinsulinaemic clamps at 14 weeks of age. 16 Basically, similar observations have been made in sheep, although at different times postnatally, giving a strong support to the hypothesis that both low insulin secretion and insulin resistance contribute to impair glucose homeostasis after IUGR. In type 2 diabetes of adults, hepatic insulin resistance and increased hepatic glucose production contribute, together with insulinopaenia and muscle insulin resistance, to the pathogenesis of hyperglycaemia. Hepatic consequences of maternal energy/protein restriction have indeed also been observed in IUGR rats. 23 Interestingly, disturbances of hepatic glucose metabolism are observed quite early after birth. 24 As early as 1 week postnatally, newborn rats display an increased expression of PEPCK and glucose-6-phosphatase genes and an impaired insulin-induced phosphorylation of insulin receptor substrate-2 in hepatocytes. These alterations lead to an impaired suppression of glucose production by insulin, which antecede any alterations of extrahepatic insulin sensitivity. Interestingly, such early alterations of glucose production have also been observed in rats fed a high-fat diet or a high-sucrose diet, and are followed after a few weeks to the development of generalized insulin resistance. 25 This suggests an hepatocentric pathogenesis of insulin resistance in which initial disturbance of hepatic metabolism secondarily leads to more widespread alterations of insulin sensitivity. In high-fat or high-sucrose fed rats, ectopic lipid accumulation appears to be involved in the development of first hepatic, and later muscle insulin resistance. Whether ectopic lipids are also involved in the alterations induced by IUGR has so far not been documented.
Human studies
Several cohorts of children born SGA have undergone detailed investigations, which indicate that many of the alterations observed in animal models are also present in humans. [26] [27] Thus, young adults born SGA were shown to have IGT compared to controls with normal birth weight. 27 Euglycaemic hyperinsulinaemic clamp studies further documented the presence of impaired suppression of hepatic glucose production, indicating hepatic insulin resistance and of decreased whole body glucose disposal rate, suggesting muscle insulin resistance. Furthermore, it was documented in muscle and adipose biopsies obtained before and after hyperinsulinaemia that insulin signalling with impaired and insulin-induced transcription of GLUT4 was decreased in these children. 28 It was also observed, using an experimental protocol involving the repeated ingestion of small doses of oral glucose and adapted to small children [29] [30] that glucose oxidation was reduced, whereas lipid oxidation was increased already at early pubertal stages in these children. 31 It is also of interest that children born SGA often have decreased post-natal growth as well. In addition, they tend to have alterations of their body composition, with increased fat mass relative to lean body mass. 31 It has long been Adiposity in children born SGA L Tappy recognized that adiposity contributes to insulin resistance, 32 possibly through increased adipose tissue lipolysis and plasma-free fatty acid concentrations. 33 It raises therefore the possibility that alterations of body composition may play a role in the development of insulin resistance in children born SGA.
Possible mechanisms involved in metabolic inprinting
The recognition that events occurring during foetal life can lead to permanent changes in metabolism and cardiovascular physiology led to the important concept of foetal inprinting. It indicates that factors distinct from gene inheritance can be modulated by unique events during the life of an individual and lead to permanent changes. It has subsequently been suggested that such 'programming' events were not restricted to foetal life, but may occur during several critical windows during development, such as the early post-natal period or puberty. Thus, it has been observed both in animal experiments and in clinical studies that early post-natal nutrition plays a significant role in the development of impaired glucose homeostasis of individuals born SGA. 
Hormonal hypothesis
Alterations of hormonal axes have also been suggested as potential factors involved in metabolic inprinting. Glucocorticoids are known to play a critical role in organ development and maturation during foetal life. The placenta express the enzyme 11b hydroxysteroid dehydrogenase 2 (11b HSD 2 ) which, by converting (in humans) active cortisol to cortisone, prevents the exposure of the foetus to excess corticoid concentrations. Interestingly, 11b HSD 2 expression is decreased in the placenta of mothers exposed to energy/ protein restriction, and is proportional to placenta size. 36 As a consequence of lower 11b HSD 2 activity during undernutrition, foetal tissues are likely to be exposed to excessive corticoid levels, which may adversely affect organ nutrition. It has indeed been reported that high glucocorticoid levels during foetal life are associated with increased blood pressure in subsequent life. 37 It may also possibly lead to permanent alterations of the regulation of the hypothalamo-pituitaryadrenal axis and of the sympatho-adrenal axis, leading to increased susceptibility to stress stimuli. 38 This remains, however, to be specifically evaluated in humans. Increased cortisol and adrenaline secretion, even if episodical, and increased sympathetic nervous system activity may in turn contribute to the development of visceral adiposity and insulin resistance. [39] [40] Of interest, children born with IUGR frequently show an impaired post-natal growth as well. Their growth hormone (GH) secretion and plasma insulin-like growth factor-1 (IGF-1) levels appear generally in the normal range. A recent report, however, indicates that plasma IGF-1 levels are slightly but significantly lower in young adults born SGA than in individuals born with a normal weight. 41 In SGA children, treatment with GH can improve growth rate, but the doses of GH to be administered are substantially larger than in children with GH deficiency. [42] [43] This suggests that IUGR may lead to a state of 'GH resistance' (Figure 1 ). Of interest, metabolic alterations observed in individuals born SGA (insulin resistance, increased adiposity) are reminiscent of those encountered in adults with GH deficiency. In the latter condition, GH replacement therapy, by increasing fat oxidation and reducing body fat improves insulin sensitivity. In children born SGA, treatment with high-dose GH surprisingly led to little adverse effects on glucose homeostasis. 42, 44 Given the well-known diabetogenic effects of high-dose GH in normal individuals, the absence of wellmarked diabetogenic effects of GH in children born SGA may support the hypothesis of a GH resistance.
Conclusion
There is now a large body of evidence indicating that low birth weight children have an increased risk of subsequently Figure 1 Hypothetic model for metabolic disorders and impaired growth secondary to GH resistance. Resistance to GH actions may (1) decrease IGF-1 secretion, thus leading to low growth rates and to impaired glucose metabolism and (2) increase body fat, leading to insulin resistance through increased plasma-free fatty acids.
developing type 2 diabetes mellitus and the metabolic syndrome. Discrete, but highly significant alterations of glucose homeostasis (insulin resistance) and of body composition (increased adiposity) are observed early during the development of these individuals, and most likely are key factors to increase the susceptibility to a diabetogenic environment (thrifty phenotype hypothesis). The mechanisms underlying the metabolic reprogramming remain to be further delineated. Epigenetic regulation of gene expression through DNA methylation is certainly a prime candidate, but permanent alterations of neuroendocrine axes such as the hypothalamo-pituitary-adrenal axis or growthhormone-IGF-1 axis may also be involved and would deserve further evaluation.
